Skip to main content

Table 2 Mean reticulocyte counts during the administration of CERA by Q2W and Q4W

From: Influence of continuous erythropoietin receptor activator (CERA) administration intervals on erythropoietic effect in hemodialysis patients

CERA dosage (μg/4 weeks)

Q2W/1000 (cells/μL)

Q4W/1000 (cells/μL)

p value

50 (N = 25)

40.7 ± 10.0

36.2 ± 9.9

<0.005

100 (N = 13)

41.6 ± 12.5

35.8 ± 7.8

<0.05

150 (N = 6)

44.7 ± 10.8

38.4 ± 7.0

<0.05

All (N = 44)

41.5 ± 10.7

36.4 ± 8.8

<0.0001

  1. Variables are represented as mean ± standard deviation